Delineating the mechanism of fragility at BCL6 breakpoint region associated with translocations in diffuse large B cell lymphoma

被引:0
|
作者
Vidya Gopalakrishnan
Urbi Roy
Shikha Srivastava
Khyati M. Kariya
Shivangi Sharma
Saniya M. Javedakar
Bibha Choudhary
Sathees C. Raghavan
机构
[1] Indian Institute of Science,Department of Biochemistry
[2] Institute of Bioinformatics and Applied Biotechnology,Department of Zoology
[3] St. Joseph’s College (Autonomous),Department of Bioscience and Biotechnology
[4] Banasthali Vidyapith,undefined
来源
关键词
Chromosomal translocations; Translocation breakpoint; Double-strand break; Lymphoid cancer; Genomic fragility; Non-B DNA; G4 DNA; Cruciform DNA; Triplex DNA;
D O I
暂无
中图分类号
学科分类号
摘要
BCL6 translocation is one of the most common chromosomal translocations in cancer and results in its enhanced expression in germinal center B cells. It involves the fusion of BCL6 with any of its twenty-six Ig and non-Ig translocation partners associated with diffuse large B cell lymphoma (DLBCL). Despite being discovered long back, the mechanism of BCL6 fragility is largely unknown. Analysis of the translocation breakpoints in 5′ UTR of BCL6 reveals the clustering of most of the breakpoints around a region termed Cluster II. In silico analysis of the breakpoint cluster sequence identified sequence motifs that could potentially fold into non-B DNA. Results revealed that the Cluster II sequence folded into overlapping hairpin structures and identified sequences that undergo base pairing at the stem region. Further, the formation of cruciform DNA blocked DNA replication. The sodium bisulfite modification assay revealed the single-strandedness of the region corresponding to hairpin DNA in both strands of the genome. Further, we report the formation of intramolecular parallel G4 and triplex DNA, at Cluster II. Taken together, our studies reveal that multiple non-canonical DNA structures exist at the BCL6 cluster II breakpoint region and contribute to the fragility leading to BCL6 translocation in DLBCL patients.
引用
收藏
相关论文
共 50 条
  • [31] Intrachromosomal translocations of BCL6: An under recognized mechanism of BCL6 deregulation in B-cell non-Hodgkin lymphomas
    Keller, CE
    Nandula, S
    Vakiani, E
    Alobeid, B
    Murty, VS
    Bhagat, G
    LABORATORY INVESTIGATION, 2006, 86 : 232A - 232A
  • [32] BCL6 gene rearrangement and other cytogenetic abnormalities in diffuse large cell lymphoma
    Offit, K
    Louie, DC
    Parsa, NZ
    Roy, P
    Leung, D
    LoCoco, F
    Zelenetz, A
    DallaFavera, R
    Chaganti, RSK
    LEUKEMIA & LYMPHOMA, 1995, 20 (1-2) : 85 - 89
  • [33] Chromosomal translocations cause deregulated BCL6 expression by promoter substitution in B cell lymphoma
    Ye, BH
    Chaganti, S
    Chang, CC
    Niu, H
    Corradini, P
    Chaganti, RSK
    DallaFavera, R
    EMBO JOURNAL, 1995, 14 (24): : 6209 - 6217
  • [34] BCL6 - A NOVEL PROTOONCOGENE INVOLVED IN THE PATHOGENESIS OF DIFFUSE LARGE-CELL LYMPHOMA
    COCO, FL
    YE, BH
    LISTA, F
    KNOWLES, DK
    OFFIT, K
    CHAGANTI, RSK
    DALLAFAVERA, R
    BLOOD, 1993, 82 (10) : A440 - A440
  • [35] High-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements with diffuse large B-cell lymphoma morphology
    Scott, David W.
    King, Rebecca L.
    Staiger, Annette M.
    Ben-Neriah, Susana
    Jiang, Aixiang
    Horn, Heike
    Mottok, Anja
    Farinha, Pedro
    Slack, Graham W.
    Ennishi, Daisuke
    Schmitz, Norbert
    Pfreundschuh, Michael
    Nowakowski, Grzegorz S.
    Kahl, Brad S.
    Connors, Joseph M.
    Gascoyne, Randy D.
    Ott, German
    Macon, William R.
    Rosenwald, Andreas
    BLOOD, 2018, 131 (18) : 2060 - 2064
  • [36] Extra copies of MYC, BCL2, and BCL6 and outcome in patients with diffuse large B-cell lymphoma
    Sermer, David
    Bobillo, Sabela
    Dogan, Ahmet
    Zhang, Yanming
    Seshan, Venkatraman
    Lavery, Jessica A.
    Batlevi, Connie
    Caron, Philip
    Hamilton, Audrey
    Hamlin, Paul
    Horwitz, Steven
    Joffe, Erel
    Kumar, Anita
    Matasar, Matthew
    Noy, Ariela
    Owens, Colette
    Moskowitz, Alison
    Palomba, M. Lia
    Straus, David
    von Keudell, Gottfried
    Rodriguez-Rivera, Ildefonso
    Falchi, Lorenzo
    Zelenetz, Andrew
    Yahalom, Joachim
    Younes, Anas
    BLOOD ADVANCES, 2020, 4 (14) : 3382 - 3390
  • [37] Targeting BCL6 in diffuse large B-cell lymphoma: what does this mean for the future treatment?
    Cerchietti, Leandro
    Melnick, Ari
    EXPERT REVIEW OF HEMATOLOGY, 2013, 6 (04) : 343 - 345
  • [38] Transcriptional deregulation of mutated BCL6 alleles by loss of negative autoregulation in diffuse large B cell lymphoma
    Pasqualucci, L
    Migliazza, A
    Ye, BH
    Dalla-Favera, R
    IMMUNE MECHANISMS AND DISEASE, 2003, 987 : 314 - 315
  • [39] A mouse model of diffuse large B-cell lymphoma induced by deregulated BCL6 expression.
    Cattoretti, G
    Pasqualucci, L
    Ballon, G
    Tam, W
    Murty, VV
    Morse, HC
    Dalla-Favera, R
    BLOOD, 2003, 102 (11) : 136A - 136A
  • [40] Mutational, immune microenvironment, and clinicopathological profiles of diffuse large B-cell lymphoma and follicular lymphoma with BCL6 rearrangement
    Carreras, Joaquim
    Ikoma, Haruka
    Kikuti, Yara Yukie
    Miyaoka, Masashi
    Hiraiwa, Shinichiro
    Tomita, Sakura
    Kondo, Yusuke
    Ito, Atsushi
    Nagase, Shunsuke
    Miura, Hisanobu
    Kawada, Hiroshi
    Roncador, Giovanna
    Campo, Elias
    Hamoudi, Rifat
    Nakamura, Naoya
    VIRCHOWS ARCHIV, 2024, 484 (04) : 657 - 676